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ABSTRACT 
MDTs is regarding as a good candidates for the patients with persistent nausea, who are traveling, or who have little or no access to water.  The 
objective of present research work was to prepare and evaluate the mouth dissolving tablet of Lacosamide using Super disintegrants like Guar 
Gum, and other excipients like Microcrystalline Cellulose and Mannitol in different concentrations by Direct Compression method. Lacosamide 
has been shown to be an effective antiepileptic agent appropriate for the epilepsy patients. Effect of different formulation variables i.e. amount 
of polymer and type of polymer was studied on release profile and other characteristics. The mouth dissolving tablets were pr epared by single 
punch machine using powder blend of superdisintegrant and Lacosamide. Post-compression parameters like Hardness, weight variation, 
friability, In-Vitro dispersion, Drug content uniformity and In-vitro drug release studies were carried out for all the formulation. All the 
Formulations gave the result within the official limits. The prepared mouth dissolving tablet shows the properties of fast disintegration time 
(28 sec to 47 sec) within official limit.  By the in-vitro disintegration, it is concluded that formulation F2 prepared by Guar Gum (10%) showed 
the fast disintegration time than the MCC. Therefore, it may be concluded that mouth dissolving tablet was suitable choice for delivery system of 
Lacosamide.  
Keywords: Lacosamide, Mouth dissolving tablets, Superdisintegrants, Guargum, microcrystalline cellulose, Direct compression method, 
Antiepileptic drug. 
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1. INTRODUCTION 
Tablet is the very commonly used dosage form because of 
the important advantages such as simplicity of self-
administration, easy to prepare, can be deliver in the 
accurate dose.1 In pediatric and geriatric patients, the solid 
dosage forms shows a difficulty in swallowing (dysphagia) or 
chewing, and it is one of the limitations of solid dosage 
forms.2 
FDTs is regarding as a good candidates for the patients with 
persistent nausea, who are traveling, or who have little or no 
access to water. As according to the United States Food and 
Drug Administration (USFDA), the FDT is defined as the solid 
dosage forms which contains the active pharmaceutical 
ingredient, which break down rapidly usually within a 
seconds when taken in the mouth. These tablets are also 
known as fast dissolving tablets, fast melting tablets.2 
                                                                         
Fig 1: Conceptual diagram of FDT 
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Lacosamide is an antiepileptic drug used to treat seizures 
and this drug is structurally unrelated to other 
anticonvulsant drugs. Lacosamide works in a very unique 
way and it shows 2 pathways of mode of action: 3, 4 
 It works by selectively enhancement of slow 
inactivation of voltage gated sodium channels, and 
helps in the stabilizing of the hyperexcitable neuronal 
brain membranes and also inhibits the neuronal firing.  
 As other antiepileptic drugs works by fast inactivation 
of the sodium channels and hence this lacosamide drug 
is having its unique mode of action. 
 This drug also acts on the receptor i.e. collapsing 
response mediator protein- 2(CRMP-2), however, its 
expression is altered in epilepsy and other 
neurodegenarative diseases. 
Lacosamide is administered by oral route and shows the 
complete absorption of the drug with having no first pass 
metabolism. In-vivo studies show that lacosamide is having 
100% bioavailability. The absorption rate and extent are not 
affected by food intake. The volume of distribution of 
lacosamide is near about 0.8 L/kg. The metabolite of 
lacosamide is O-desmethyl metabolite which is not having 
any pharmacological activity. The enzymes involved in the 
metabolism process is CYP isoenzyme 2C19 which is mainly 
responsible for the formation of the O-desmethyl metabolite, 
although in vitro data suggest that also CYP3A4 and CYP2C9 
may be involved. The half-life of this drug was found to be 
near about 13 hrs, allowing convenient BID dosing. 
Lacosamide is mainly excreted by renal route. 
 
 
 
2. MATERIALS AND METHODS 
2.1. Materials: 
Lacosamide was obtained from Jubilant Chemsys (Research 
and development) Noida, India, Guargum was obtained from 
CDH (Central Drug House) Ltd, New Delhi-11002 (India), 
Microcrystalline Cellulose was obtained from Loba Chemie 
Ltd., Mumbai, India, All other reagents and chemicals used 
were of analytical grade. 
2.2. Methods: 
2.2.1. Determination of λ
max 
of Lacosamide and 
preparation of calibration curve 
The standard curve of lacosamide is prepared by firstly 
preparing the stock solution of 100 mcg/ml. The stock 
solution was prepared by taking accurately weighed 5 mg of 
drug (Lacosamide) and dissolve in the 50 ml of phosphate 
buffer of pH 6.9 in a volumetric flask. From the above 
prepared stock solution, different dilutions such as (2, 4, 6, 8, 
10, 12 mcg/ml) were prepared and the absorbance at which 
calibration curve has to be obtained was scanned at 206 nm 
in UV Spectrophotometer. After taking the absorbance, the 
calibration curve was prepared by taking the concentration 
on X-axis and absorbance on Y-axis. 
 2.2.2. Formulation of Mouth Dissolving Tablets 
Initially pure drug (Lacosamide) and all polymers (Guargum, 
Microcrystalline cellulose & Mannitol) were taken together 
and screened through sieve having mesh size # 60 and co 
grind in a mortar and pestle. Then lubricant & glidant are 
added in the mixture after passing through sieve of mesh size 
# 60 to improve the flow properties. Then the mixture is 
thoroughly mixed. Then the prepared mixture was 
compressed into tablet to prepare 200 mg convex faced 
tablet by using 8mm round punches on multipunch tablet 
compression machine. 
 
Table 1: Formulation of Lacosamide mouth dissolving tablets 
 
Ingredients (mg) 
Formulation code 
F1 F2 F3 F4 F5 
Lacosamide 50 50 50 50 50 
Guar gum 10 10 20 - - 
Mannitol 100 110 100 100 110 
Microcrystalline cellulose 10 - - 20 10 
Aspartame 4 4 4 4 4 
Starch 20 20 20 20 20 
Talc 4 4 4 4 4 
Magnesium stearate 2 2 2 2 2 
Vanilline q.s q.s q.s q.s q.s 
Total weight (mg) 200 200 200 200 200 
 
2.2.3. Evaluation of powder blends (pre-compression): 
2.2.3.1. Angle of repose: 
Angle of repose is one of the evaluation parameters for study 
the flow properties of powder. This analysis can be done by 
using funnel method in which funnel used and kept vertically 
at 6.3 cm height. Then the powder is poured by the upper 
side and closing the end of funnel with the help of thumb 
until powder is completely filled in the funnel. After pouring 
powder completely, the pile was formed by which radius of 
the heap can be measured and then the angle of repose was 
calculated by the following formula. 5, 6 
θ=tan-1 (h/r) 
Where h is the height of pile and r is the radius of the base of 
the pile. 
2.2.3.2. Bulk density (BD): 
This is one of the preformulation parameters to be studied 
before going to the formulation. This type of analysis is 
studied for improving the flow properties. Bulk density is the 
ratio of total mass of the powder to the bulk volume of the 
powder. This can be determined with the help of the cylinder 
in which weight powder (passed through standard sieve # 
20) is poured into the cylinder and initial weight was noted. 
This initial volume is called the bulk volume. Then the bulk 
density can be measured by the following formula i.e,  
Db = M/ Vb. It is expressed in g/ml. 
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Where, M = mass of powder 
Vb = bulk volume of the powder. 
2.2.3.3 Tapped density (TD):  
This is analysis parameter to study the flow properties. It is 
the ratio of total mass of the powder to the tapped volume of 
the powder. The tapped density can be determined by 
tapping the powder for 750 times and then tapped volume 
was noted and if the difference between these 2 volumes i.e. 
initial as well as after tapping volume is less than 2%, If it is 
more than 2%, tapping is continued for 1250 times and 
tapped volume was noted. It is expressed in g/ml and is 
given by 
Dt = M / Vt 
Where, M is the mass of powder 
Vt is the tapped volume of the powder. 
2.2.3.4. Compressibility index and hausner ratio: 
These are the analysis for the determination of the flow 
properties of powder. It is expressed in percentage and is 
give (Table 2) 
I = (Dt – Db)/ Dt x100 
Dt:  tapped density of the powder 
Db:  bulk density of the powder. 
        Table 2: Relationship between % compressibility 
and flow ability 7, 8 
% Compressibility Flow ability 
5-10 Excellent 
12-16 Good 
18-21 Fair Passable 
23-25 Poor 
33-38 Very Poor 
<40 Very Very Poor 
 
2.2.4. Evaluation of Lacosamide fast dissolving tablets 
(Post compression): 
All the tablets were evaluated for different parameters such 
as weight variation, hardness, friability, disintegration time, 
wetting time, drug content, water absorption ratio and in 
vitro dissolution. 
2.2.4.1. Weight variation: 
This is one of the tests for the evaluation of the tablets in 
which 20 tablets are taken randomly from the batch and then 
weighed individually, to check the weight variation. Then the 
weight variation is calculated by calculating the difference 
between average and individual weight. 
Weight variation specification as per I.P.  
Table 3: Weight variation specification as per I.P 9, 10 
Average Weight of Tablet % Deviation 
80 mg or less • ±10 
80 mg to 250 mg • ±7.5 
250 mg or more • ±5 
 
2.2.4.2. Friability: 
This test is very important to study to check the effects of the 
shocks and friction during transportation. It checks the tablet 
chipping or any break of the tablet. Roche friabilator is used 
to test the friability of the tablet. ‘This friabilator helps to 
measure the effect of abrasion or shock by keeping the 20 
tablets in the plastic chamber that revolves at 25 rpm at a 
distance of 6 inches with each revolution. Initially the weight 
was measured before keeping the tablets in friabilator, which 
was then operated for 100 revolutions. Tablets were dusted 
and reweighed. Compressed tablets should not loose more 
than 1% of their weight 11 
F = Wt initial–Wt final / Wt initial x 100 
2.2.4.3. Disintegration time: 
This is the evaluation parameter to determine the time to 
break the tablet in the oral cavity so to measure the drug 
action. The disintegration time can be calculated by placing 
the 6 tablets in each tube of the apparatus having 6 tubes. 
This apparatus contains the distilled water at 37ºC±2ºC was 
used as a disintegration media. Then the time to break the 
tablet was noted which determines the action of the drug. 
2.2.4.4. Wetting time: 12 
This is very important to determine in case of mouth 
dissolving tablets which depends on the inner structure of 
the tablet as well as hydrophilicity of the excipient. The 
water penetration rate determines the wetting time which 
depends on the hydrophilicity of the powders. 
dl/dt = r¡cosq/ (4hl) 
Where l is the length of penetration, r is the capillary radius, 
! is the surface tension,  
h is the liquid viscosity,  
t is the time,  
q is the contact angle. 
2.2.4.5. Water absorption ratio: 
The weight of the tablet before keeping in Petri-dish was 
noted (Wb). Fully wetted tablet from the Petri-dish was 
taken and reweighed (Wa). The water absorption ratio R can 
be determined according to the following formula: 
R= (Wa-Wb)/Wa×100 
2.2.4.6. Drug content: 
Ten tablets from each formulation were powdered. The 
powder equivalent to 100 mg of Lacosamide was weighed 
and dissolved in suitable amount of methanol and volume 
was made up to 100 ml with phosphate buffer (pH 6.8). The 
solution was sonicated for 5 min. Then solution was filtered 
through Whatman filter paper and then suitable dilution was 
prepared and it was analyzed at 206 nm by UV 
spectrophotometer. 
2.2.4.7. In vitro release study: 
This test is conducted for the prepared fast dissolve tablets 
for a period of 12 min using a six-station USP type II (paddle) 
apparatus at 37oC and 50 rpm speed. The sampling of ODT’s 
was done after every 2 min interval in which 5 ml of the 
sample was withdrawn and replaced with fresh medium to 
maintain the volume constant. Then the absorbance was 
measured in UV spectrophotometer at λ max 206nm. 
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3. RESULTS AND DISCUSSION 
3.1. Characterization of blend for fast dissolving tablets: 
The data for evaluation of powder blends of rapidly 
disintegrating tablets of Lacosamide are shown in Table 4. 
The pre-compression parameters values were within limits 
and indicated good free flowing property. The angle of 
repose was in the range 26.84±0.48 to 28.93±0.59 indicating 
good flow property. The compressibility index was in the 
range of 13.38±0.26 to 15.38±0.29. The Bulk and Tapped 
density were in the range of 0.43±0.01 to 0.44±0.01 and 
0.51±0.01 to 0.52±0.01 respectively. 
 
Table 4: Evaluation of powder blends (Pre-formulation study) 
S.No. Formulation Code Angle of repose Bulk Density 
Tapped 
Density 
Carr’s Index 
1. F1 28.93±0.59 0.44±0.01 0.52±0.01 15.38±0.29 
2. F2 27.15±0.52 0.44±0.01 0.52±0.01 15.28±0.16 
3. F3 27.77±0.45 0.43±0.01 0.51±0.01 13.38±0.26 
4. F4 26.84±0.48 0.44±0.01 0.51±0.01 15.38±0.29 
5. F5 27.74±0.50 0.43±0.01 0.52±0.01 14.92±0.85 
All the readings are expressed as mean ± standard deviation (n=3) 
 
3.2. Evaluation of Lacosamide fast dissolving tablets: 
Mouth dissolving tablets of Lacosamide were prepared by 
direct compression method using Guargum as a 
superdisintegrant, Microcrystalline cellulose as a 
disintegrant and mannitol serves as diluent in Table 1. The 
preparation of mouth dissolving tablets using 
superdisintegrants has proven to be highly effective and 
commercially convenient. They were taken in various ratios 
to find the optimum concentration of the superdisintegrants 
required to yield formulation providing least wetting time, 
minimum disintegration time and get maximum drug 
release. The superdisintegrants were used alone as low as 
10% to as high as 20% in fast dissolving formulations to 
improve dissolution of Lacosamide. Five formulations were 
designed including the formula without superdisintegrant. 
The data obtained from post compression parameters such 
as hardness, friability, uniformity of weight, drug content, 
wetting time, disintegration and water absorption ratio are 
shown in Table 3. 
 
Table 3: Evaluation parameters of mouth dissolving tablets of Lacosamide 
Formulation 
code 
Thickness Hardness 
Disintegration 
time (sec) 
Weight 
variation 
F1 3.67±0.045 4.0±0.002 47 200 
F2 3.75±0.065 3.91±0.204 28 202 
F3 3.72±0.048 3.83±0.258 38 200 
F4 3.74±0.049 3.90±0.201 30 200 
F5 3.73±0.040 3.80±0.204 37 202 
 
Table 4: Evaluation parameters of mouth dissolving tablets of Lacosamide 
Formulation 
code 
Friability 
% 
Wetting time 
(sec) 
Water absorption 
ratio (%) 
Drug Content 
(mg%) 
F1 0.42 3.53±2.59 55.81±1.47 99.95±0.70 
F2 0.49 3.48±2.42 60.32±1.45 100.03±1.14 
F3 0.58 3.54±1.47 59.93±1.90 99.96±1.18 
F4 0.55 3.52±2.50 62.22±1.35 100.43±0.90 
F5 0.56 3.27±2.26 68.50±2.24 99.43±1.20 
 
The drug content of all the prepared tablets was in the range 
of 99.43±0.90 to 100.43±0.90%. Hardness of the tablets was 
found to be in the range of 4.0±0.002 to 3.80±0.204 kg/cm2. 
Tablet hardness difference is an indication of tablet density 
and porosity variations. It has been presumed that these 
differences influence the rate of penetration of the 
dissolution fluid at the surface of the tablet which 
consequently affects the release pattern. Uniformity of 
weight was found to be in the range of 200 to 202 mg which 
is complying with USP specifications within an acceptable 
range of ±5%. The friability of the formulated tablets was 
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less than 1% which was in the range of 0.42 to 0.58% in 
Table 3. The capacity of the disintegrant to swell in the 
presence of little amount of water is governed by water 
absorption ratio and wetting time. Determination of wetting 
time is an important confirmative test for mouth dissolving 
tablet evaluation as the dissolution profile of a tablet 
depends on its wetting prior to disintegration. The wetting 
time for all the prepared tablets was in the range of 
3.27±2.26 to 3.54±1.47 sec. The wetting time decreased with 
increase in the level of guargum (10-20%). The lowest 
wetting time was observed for F2 containing 10% guargum 
as superdisintegrant. The water absorption ratio was found 
to be in the range of 55.81±1.47 to 68.50±2.24 %. The 
disintegration time of all the formulated tablets was 
between 28 to 47sec, this was found to be well within the 
acceptable limit for fast dissolving tablet (< 3 min.). 
3.3. In vitro dissolution study: 
The release rate of Lacosamide from mouth dissolving 
tablets was determined using USP Dissolution Testing 
Apparatus II (Paddle type). The dissolution medium used 
was 900 ml of phosphate buffer pH 6.8 which was 
maintained at 37±0.50C. The paddle speed was kept at 50 
rpm throughout the study. Five ml of samples was 
withdrawn at every 2 minutes interval and diluted to 10ml 
then 5ml of fresh dissolution media maintained at the same 
temperature was replaced. The samples were analyzed 
spectrophotometrically at 206 nm using phosphate buffer 
pH 6.8 as blank. The raw dissolution data was analyzed for 
calculating the amount of drug released and percentage 
cumulative drug released at different time intervals. 
 
Table 5: Details of Dissolution Test: 
S.No Requirement Specification 
1. Apparatus USP Type II 
2. Volume of medium 900 ml 
3. Temperature 37±0.50C 
4. Paddle Speed 50 rpm 
5. Dissolution medium used 6.8 phosphate buffer 
6. A liquid  taken at each time interval 5 ml 
 
Table 6: Comparative Cumulative Drug Release of Different Formulations 
S. No 
Time 
(Min) 
Comparative Cumulative Release of Different Formulations 
F1 F2 F3 F4 F5 
1. 0 0 0 0 0 0 
2. 2 15.15±0.73 18.96±0.73 28.34±1.26 18.21±0.67 20.21±0.77 
3. 4 29.53±0.32 35.14±0.39 40.08±0.32 35.85±0.31 42.85±0.40 
4. 6 44.79±0.96 50.71±0.50 52.7±0.77 48.93±0.49 60.90±0.50 
5. 8 60.09±0.73 62.64±0.57 64.05±0.95 56.24±0.31 72.20±0.55 
6. 10 74.74±0.44 78.80±0.37 76.25±0.50 78.8±0.81 84.10±0.27 
7. 12 92.94±0.69 99.86±0.54 90.17±1.14 92.66±0.47 95.66±0.50 
aMean ± S.D.(n=3) 
 
 
Figure 1: Comparative Study of Cummulative Release of different Formulations 
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Figure 2: Comparative Study of Cummulative Release of different Formulations 
 
4. CONCLUSION 
The fast dissolving tablets of lacosamide were successfully 
prepared by direct compression method by using 
superdisintegrants and the objective of this study was 
achieved. By the in-vitro disintegration, it is concluded that 
formulation F2 prepared by Guar Gum (10%) showed the 
fast disintegration time than the MCC. 
So it represent that the use of superdisintegrants, it increases 
the release of the drug Lacosamide. Therefore, it may be 
concluded that mouth dissolving tablet was suitable drug 
delivery system for Lacosamide.  
Thus, the fast dissolving tablets are successfully prepared for 
the patients who are suffering from difficulty of swallowing 
or dysphagia, the patients mainly for paediatric, geriatric, or 
the patients who have no access of water, and also provides 
faster and better drug release, thereby, improving the 
bioavailability of drug as compared to the conventional 
marketed formulation. 
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